The aim of this study was to evaluate the expression levels of TP53, C-MYC, FBL, and NCL in pre-B ALL and neuroblastoma tissues compared to healthy bone marrow samples. This evidence concerns the gene NUCLEOLIN and acute lymphoblastic leukemia.